Despite accounting for 12.6% of global GLP-1 clinical trial activity in 2025, placing it third globally behind the US and China, prescribing rates for obesity indications remain comparatively low
What does the article say to verify before buying GLP-1 from any source
J Clin Invest 125:21612170
Up until 2023, pediatricians were advised to apply a watchful waiting approach with patients diagnosed with obesity, and to recommend lifestyle treatments aimed at healthier eating and exercise habits
Adjust Patient Communication Speak to informed consumers familiar with GLP-1s, not just brand names
Serum T 4 is monitored by the HPT axis, which, in normal individuals, will generate the correct amount of TH